Skip to NavigationSkip to content

Pharmafile - Research and Development News

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes it has found the man in John...
From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the most recent offer reach...
AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it from its rivals, after...
With in-depth features on mobile health, clinical trials and Brexit, and the future of patient-reported outcomes, as well as interviews with Amicus...
Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead drug candidate, NEOD001, had both missed the mark.
Novartis will expand its current partnership with Pear Therapeutics, as it reveals that its generic and biologics arm Sandoz will work with the...
It's the end of another week and there's really been one story that has dominated the headlines – Takeda’s potential takeover of Shire. It should...
The FDA has announced its approval of a combination of Opdivo and Yervoy for the treatment of previously untreated advanced renal cell carcinoma...
Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK and Canada, but...
Amgen has lifted the curtain on complete Phase 3 data for Aimovig in the treatment of episodic migraine in patients who had previously failed two to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches